Total Payments
$12,536
2024 Payments
$2,614
Companies
30
Transactions
519
Medicare Patients
237
Medicare Billing
$21,571
Payment Breakdown by Category
Food & Beverage$12,536 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,536 | 519 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $1,350 | 44 | $0 (2024) |
| Validus Pharmaceuticals LLC | $1,348 | 8 | $0 (2023) |
| ABBVIE INC. | $1,247 | 66 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,015 | 44 | $0 (2024) |
| Lundbeck LLC | $959.04 | 49 | $0 (2024) |
| Axsome Therapeutics, Inc. | $788.89 | 24 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $753.10 | 38 | $0 (2024) |
| ITI, Inc. | $738.17 | 39 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $696.61 | 29 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $582.38 | 31 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,614 | 123 | Lundbeck LLC ($304.35) |
| 2023 | $3,092 | 147 | ABBVIE INC. ($541.57) |
| 2022 | $2,584 | 116 | Alkermes, Inc. ($601.46) |
| 2021 | $4,246 | 133 | Validus Pharmaceuticals LLC ($1,316) |
All Payment Transactions
519 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 12/16/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: ANTI-ANXIETY | ||||||
| 12/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $30.08 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $22.30 | General |
| Category: PSYCHIATRY | ||||||
| 12/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $31.95 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/04/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 12/03/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: Neuropsychiatry | ||||||
| 12/02/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Central Nervous System | ||||||
| 11/26/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $24.23 | General |
| Category: PSYCHIATRY | ||||||
| 11/25/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: PSYCHIATRY | ||||||
| 11/25/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $29.40 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/19/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: CNS | ||||||
| 11/18/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Neurology | ||||||
| 11/13/2024 | Orexo US, Inc. | Zubsolv (Drug) | Food and Beverage | Cash or cash equivalent | $17.24 | General |
| Category: Addiction Medicine | ||||||
| 11/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $26.45 | General |
| Category: PSYCHIATRY | ||||||
| 11/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.68 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | Cash or cash equivalent | $123.80 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/06/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Neuropsychiatry | ||||||
| 11/06/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/05/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $25.11 | General |
| Category: Neuropsychiatry | ||||||
| 11/04/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Central Nervous System | ||||||
| 10/29/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: PSYCHIATRY | ||||||
| 10/28/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 26 | 33 | $5,615 | $1,899 |
| 2022 | 2 | 47 | 63 | $9,975 | $3,599 |
| 2021 | 2 | 77 | 144 | $21,360 | $8,137 |
| 2020 | 2 | 87 | 135 | $20,195 | $7,936 |
Total Patients
237
Total Services
375
Medicare Billing
$21,571
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 19 | $3,515 | $1,232 | 35.0% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 11 | 14 | $2,100 | $666.54 | 31.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 25 | 35 | $6,125 | $2,258 | 36.9% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 22 | 28 | $3,850 | $1,342 | 34.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 41 | 84 | $13,860 | $5,263 | 38.0% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 36 | 60 | $7,500 | $2,873 | 38.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 49 | 83 | $13,695 | $5,053 | 36.9% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 38 | 52 | $6,500 | $2,883 | 44.3% |
About Carreen Castroll, NP
Carreen Castroll, NP is a Psychiatric/Mental Health healthcare provider based in Coram, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/25/2009. The National Provider Identifier (NPI) number assigned to this provider is 1639313398.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Carreen Castroll, NP has received a total of $12,536 in payments from pharmaceutical and medical device companies, with $2,614 received in 2024. These payments were reported across 519 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($12,536).
As a Medicare-enrolled provider, Castroll has provided services to 237 Medicare beneficiaries, totaling 375 services with total Medicare billing of $21,571. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatric/Mental Health
- Location Coram, NY
- Active Since 04/25/2009
- Last Updated 04/25/2009
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1639313398
Products in Payments
- Equetro (Drug) $1,348
- VRAYLAR (Drug) $1,247
- REXULTI (Drug) $1,097
- ARISTADA (Drug) $1,093
- CAPLYTA (Drug) $982.07
- TRINTELLIX (Drug) $753.10
- INGREZZA (Drug) $696.61
- AUSTEDO (Drug) $649.35
- Sunosi (Drug) $629.55
- ABILIFY MAINTENA (Drug) $390.68
- Austedo XR (Drug) $365.40
- QUVIVIQ (Drug) $337.83
- BELSOMRA (Drug) $331.13
- HETLIOZ (Drug) $310.42
- LATUDA (Drug) $302.25
- APLENZIN (Drug) $291.56
- LYBALVI (Drug) $257.63
- Auvelity (Drug) $159.34
- FANAPT (Drug) $144.42
- SUNOSI (Drug) $135.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.